|
Report Date : |
08.05.2012 |
IDENTIFICATION DETAILS
|
Name : |
DRUGMAKER’S LABORATORIES, INC. |
|
|
|
|
Formerly Known As : |
DRUGMAKER’S LABORATORY, INC. |
|
|
|
|
Registered Office : |
E & E Industrial Complex, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2010 |
|
|
|
|
Date of Incorporation : |
19.08.1976 |
|
|
|
|
Com. Reg. No.: |
69184 |
|
|
|
|
Legal Form : |
Corporation |
|
|
|
|
Line of Business : |
Manufacturer, distributor, and toll contractor of pharmaceutical, health care, cosmetic, beauty care, veterinary, and agricultural products. |
|
|
|
|
No. of Employees : |
315 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
|
B1 |
B1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
Company
Name: |
DRUGMAKER’S
LABORATORIES, INC. |
|
Former
Name: |
DRUGMAKER’S
LABORATORY, INC. |
|
Supplied
Name: |
Drugmakers Laboratories Inc |
|
Trading Address: |
E
& E Industrial Complex, Narra Road, Brgy. San Antonio, San Pedro 4023, Laguna, Philippines |
|
Supplied
Address: |
E xe Industrial Complex Narra
Road, Brgy San Antonio san Pedro Laguna Philippines |
|
Telephone
Number: |
+632
771-0169; 771-0135; 771-0161; 556-7749/26/61/47 |
|
Fax Number: |
+632
771-0131; 771-0148; 771-0138 |
Note:
The subject’s complete exact name and address are shown as above.
|
Registered
Number: |
69184 |
|
Legal Form: |
Corporation |
|
Date
Incorporated: |
|
|
Authorized
Capital Stock: |
PHP 105,000,000 (USD 2,485,350) (As of 2012.5, 1 PHP = 0.02367 USD) |
|
Subscribed
Capital Stock: |
PHP 28,092,100 (USD 664,940) |
|
Paid-up Capital: |
PHP 10,918,300 (USD 258,436) |
|
Par Value Per
Share: |
PHP 100 |
|
Listed at Stock
Exchange: |
No |
|
Staff: |
315 Employees |
Note: Amounts in Philippine Peso unless
otherwise specified.
Corporation
Verification with the
local registry revealed the following correct registration details as of (May
3, 2012).
|
Regulatory Agency |
Date Registered |
Registration No. |
Term |
|
Securities and Exchange Commission |
|
69184 |
50 years |
Originally registered as Drugmaker's Laboratory, Inc.
Present name was approved by the
Securities and Exchange Commission on April 3, 1979.
On March 29, 2007, the Securities
and Exchange Commission approved the merger between subject and Drugmakers Biotech Research Laboratories, Inc.; Biotech
Research Laboratories, Inc., with subject as the surviving entity.
|
|
As of Common |
|
Authorized capital stock |
105,000,000.00 |
|
Subscribed capital stock |
28,092,100.00 |
|
Paid-up capital |
10,918,300.00 |
|
Par value per share |
100.00 |
Stockholders (
|
Name: |
Amount Subscribed: (PHP) |
Amount Paid-up: (PHP) |
Nationality: |
|
DEL MUNDO, ELIEZER V. |
19,434,100.00 |
7,553,280.00 |
Filipino |
|
DEL MUNDO, EVANGELINE C. |
4,655,000.00 |
1,809,162.00 |
Filipino |
|
DEL MUNDO, ANGELITA V. |
2,809,200.00 |
1,091,830.00 |
Filipino |
|
DEL MUNDO, ELIEZER G. JR. |
561,800.00 |
218,366.00 |
Filipino |
|
MAGBAG, EMMANUEL |
280,900.00 |
109,183.00 |
Filipino |
|
LIUSON, BENJAMIN |
280,900.00 |
109,183.00 |
Filipino |
|
IGNACIO, ELEANOR |
70,200.00 |
27,296.00 |
Filipino |
Management (
|
Name: |
Position: |
|
DEL MUNDO, ELIEZER V. |
Chairman / President |
|
DEL MUNDO, EVANGELINE C. |
Vice President / Director |
|
SERVIDAD, DAYRELLE S. |
Treasurer |
|
DEL MUNDO, ELIEZER G. JR. |
Corporate Secretary / Director |
|
BAGUNAS, ELMOR S. |
Assistant Corporate Secretary |
|
IGNACIO, ELEANOR |
Director |
|
VELASCO, CESAR R. |
Director |
|
Activities |
|
Manufacturer,
distributor, and toll contractor of pharmaceutical, health care, cosmetic,
beauty care, veterinary, and agricultural products. |
Unit: PHP
|
Balance Sheet |
2010.12.31 |
2009.12.31 |
|
TotalCurrentAssets |
236,666,676.00 |
237,383,966.00 |
|
Cash |
1,357,546.00 |
1,948,762.00 |
|
ShortInvest |
0 |
0 |
|
Receivable |
5,734,755.00 |
10,523,365.00 |
|
Inventory |
227,529,720.00 |
224,634,022.00 |
|
OtherCurrentAssets |
2,044,655.00 |
277,817.00 |
|
LongInvestTotal |
0 |
0 |
|
LongInvestSecurity |
0 |
0 |
|
LongInvestEquity |
117,829,959.00 |
190,915,154.00 |
|
LongInvestOther |
0 |
0 |
|
FixedAssetsTotal |
234,893,478.00 |
300,442,286.00 |
|
FixedAssets |
234,893,478.00 |
300,442,286.00 |
|
DepreciationTotal |
0 |
0 |
|
IntangibleAssets |
0 |
0 |
|
OtherAssets |
0 |
0 |
|
TotalAssets |
589,390,113.00 |
728,741,406.00 |
|
TotalCurrentDebt |
253,679,441.00 |
241,235,211.00 |
|
ShortLoan |
0 |
0 |
|
AccountsPayable |
253,352,372.00 |
240,645,089.00 |
|
OtherCurrentLiability |
327,069.00 |
590,122.00 |
|
LongLiabilityTotal |
0 |
0 |
|
LongLeases |
0 |
0 |
|
LongLoan |
0 |
0 |
|
LongLoanOther |
279,235,702.00 |
279,235,702.00 |
|
TotalLiability |
532,915,143.00 |
520,470,913.00 |
|
TotalEquity |
56,474,970.00 |
208,270,493.00 |
|
TotalEquity
(USD) |
1,336,762.54 |
4,929,762.57 |
|
ShareCapital |
0 |
0 |
|
CapitalPaid |
35,149,504.00 |
35,149,504.00 |
|
LegalReserve |
0 |
0 |
|
SurplusReserve |
0 |
152,434,275.00 |
|
UndistributedProfit |
0 |
0 |
|
RetainedEarning |
21,325,466.00 |
20,686,714.00 |
|
OtherEquity |
0 |
0 |
|
TotalLiabilityAndEquity |
589,390,113.00 |
728,741,406.00 |
|
TotalLiabilityAndEquity
(USD) |
13,950,863.97 |
17,249,309.08 |
(As of 2012.5, 1 PHP = 0.02367 USD)
Unit: PHP
|
|
2010 |
2009 |
|
OperatingRevenue |
0 |
0 |
|
SalesRevenue |
229,357,762.00 |
307,178,866.00 |
|
SalesRevenue
(USD) |
5,428,898.23 |
7,270,923.76 |
|
InterestRevenue |
0 |
0 |
|
OtherRevenue |
63,714.00 |
95,628.00 |
|
TotalRevenue |
229,421,476.00 |
307,274,494.00 |
|
SalesCost |
207,447,687.00 |
273,608,025.00 |
|
GrossProfit |
21,910,075.00 |
33,570,841.00 |
|
SalesExpenses |
0 |
0 |
|
ManagementExpenses |
21,088,591.00 |
28,673,231.00 |
|
FinancialExpenses |
0 |
0 |
|
TotalExpenses |
228,536,278.00 |
302,281,256.00 |
|
OperatingProfit |
885,198.00 |
4,993,238.00 |
|
NonOperatingProfit |
0 |
0 |
|
ProfitBeforeTax |
885,198.00 |
4,993,238.00 |
|
Tax |
246,445.00 |
1,469,283.00 |
|
NetProfit |
638,753.00 |
3,523,955.00 |
|
NetProfit
(USD) |
15,119.28 |
83,412.01 |
(As of 2012.5, 1 PHP = 0.02367 USD)
Unit: PHP
|
|
2010 |
2009 |
|
OperatingNetCash |
15,342,549.00 |
29,058,116.00 |
|
InvestmentNetCash |
-15,933,765.00 |
-30,525,710.00 |
|
FinanceNetCash |
0 |
0 |
No dealings based on credit exposure report with one million and above
dealings under the names “DRUGMAKER’S LABORATORIES, INC. / DRUGMAKER’S LABORATORY,
INC.” as of December 31, 2011.
No negative
records (court cases, credit cards cancelled and delinquent accounts) found
under the names “DRUGMAKER’S LABORATORIES, INC. / DRUGMAKER’S LABORATORY, INC.”
in our available database as of May 3, 2012.
Above information were based on the subject’s 2012 General Information
Sheet, the latest available at the Securities and Exchange Commission and our
available databases.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.53.34 |
|
UK Pound |
1 |
Rs.86.09 |
|
Euro |
1 |
Rs.69.37 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect.
Satisfactory capability for payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.